bladder carcinoma
Recently Published Documents


TOTAL DOCUMENTS

2710
(FIVE YEARS 304)

H-INDEX

83
(FIVE YEARS 6)

2022 ◽  
Vol 2022 ◽  
pp. 1-6
Author(s):  
Weiwei Zhao ◽  
Yanxuan Gong ◽  
Yugang Chen

Background. Gall Bladder Cancer (GBC) is a type of extremely malignant tumor, which has high incidences of mortality. There is rare information about its mechanisms of invasion and gene expression regulations. microRNA-155 (miR-155) has mostly been reported to be over expressed in cases of solid tumors and hematopoietic malignancies. In this study, we have investigated the role and clinical significance of miR-155 in a Chinese population suffering from GBC and compared the results with nonneoplastic inflammation. Methods. Tissue specimens were collected on 50 patients of Gall Bladder Carcinoma and 10 patients suffering from nonneoplastic inflammation who have undergone surgeries at the Department of Pathology, Renji Hospital, Shanghai, from January 2019 to January 2020. We performed profiling of miR-155 expression in both nonneoplastic and gall bladder carcinoma tissues by QRT-PCR. Results. Expression levels of miR-155 were found to be extremely high in GBC patients in comparison to the nonneoplastic tissues ( ∗ P < 0.05 ), as high miRNA is correlated with TNM stages. Further results noted were that miR-145-5p expressed genes mimic the gene expression of STAT1, a downregulation of IRF7 was noted in the GBC, and an activation of STAT1 was significantly noted in carcinoma cells of the gallbladder. Downregulation of PTPRF was also noted during the expression of miR-145. Conclusions. As downregulation of IRF7 is linked with low rates of survival, it was found that gall bladder carcinoma patients may face high mortality. The STAT-1 expression of unregulated in GBC patients was also noted.


2022 ◽  
Vol 15 ◽  
pp. 117864692110656
Author(s):  
Hellen Joyce Sousa Pereira Santos ◽  
Luiz Henrique Gomes Matheus ◽  
Aline Silva ◽  
Stephanie Vanin Dalmazzo ◽  
Andressa Assunção Santos ◽  
...  

The severity of the bladder carcinoma (BC) is directly linked to cell invasion and metastasis. Indoleamine 2,3-dioxygenase-1 (IDO-1) is an INF-γ-induced immunomodulating enzyme that has been linked to the cancer cell invasiveness. Because IDO1 is variable among the tumors, we analyzed its expression in the BC invasion using BC mice models and cell culture. MB49 cells were orthotopically or ectopically inoculated in C57Bl6 mice to evaluate IDO1 by immunohistochemistry. For in vitro experiments, expression of IDO1 and INF-γ was evaluated in grade-1 (RT4) and in grade-3 (T24) BC cell lines. Invading and non-invading T24 cells were separated using the Matrigel/Transwell system, of which total RNA was extracted immediately or after 2 weeks of subculture. Finally, IDO1 was silenced in T24 cells to verify its role on cell invasiveness. In both animal models, IDO1 was differentially expressed between non-invading and invading cells. In cell culture, T24 cells expressed more IDO1 than RT4 cells, independently of the INF-γ expression. IDO1 was differentially expressed between non-invading and invading T24 cells, a difference that was lost by long-time subculture. IDO1 silencing resulted in diminished cell invasiveness. In conclusion, IDO1 expression is changed during bladder carcinoma invasion, playing an important role in this process.


2021 ◽  
Author(s):  
Huifeng Cao ◽  
Dayin Chen ◽  
Zhihui Zhang ◽  
Liang Cheng ◽  
Zhenguo Luo ◽  
...  

Abstract Objectives: Bladder carcinoma (BLCA) is one of the most common malignant diseases of urinary system. Our study aimed to investigate the autophagy-related signatures in the tumor immune microenvironment and construct effective prognosis prediction model.Methods: RNA sequencing data and corresponding clinical information of BLCA were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). Autophagy-related genes were extracted from TCGA dataset for consensus clustering analysis, and differences in survival rate were analyzed. STIMATE algorithm was used to analyze the tumor microenvironment (TME) and immune cell infiltration was compared between different clusters. Differentially expressed genes (DEGs) between different clusters were identified, followed by function annotation. Independent prognostic signatures were further revealed to construct prognostic prediction model.Results: We identified 35 autophagy-related genes associated with prognosis. Survival rate of samples in cluster 1 was significant lower than that in cluster 2. Cluster 2 had markedly lower tumor purity and significantly higher estimate score and stromal score than cluster 1. The proportions of T cells CD8, macrophages M1, T cells CD4 memory activated, NK cells activated, and dendritic cells activated were higher in cluster 1. There were 1,275 DEGs which were mainly enriched in functions and pathways related to immune response and cancer. Seven genes (ATF6, CAPN2, NAMPT, NPC1, P4HB, PIK3C3, and RPTOR) were further identified as the independent prognostic signatures to construct risk score prediction model, which had good prediction performance.Conclusion: Prognosis prediction model based on 7 autophagy-related genes may have great value in BLCA prognosis prediction.


2021 ◽  
Vol 23 (1) ◽  
pp. 26
Author(s):  
Anna Jagusiak ◽  
Tomasz Gosiewski ◽  
Dorota Romaniszyn ◽  
Małgorzata Lasota ◽  
Anna Wiśniewska ◽  
...  

According to the World Health Organization report, the increasing antibiotic resistance of microorganisms is one of the biggest global health problems. The percentage of bacterial strains showing multidrug resistance (MDR) to commonly used antibiotics is growing rapidly. Therefore, the search for alternative solutions to antibiotic therapy has become critical to combat this phenomenon. It is especially important as frequent and recurring infections can cause cancer. One example of this phenomenon is urinary tract infections that can contribute to the development of human urinary bladder carcinoma. This tumor is one of the most common malignant neoplasms in humans. It occurs almost three times more often in men than in women, and in terms of the number of cases, it is the fifth malignant neoplasm after prostate, lung, colon, and stomach cancer. The risk of developing the disease increases with age. Despite the improvement of its treatment methods, the current outcome in the advanced stages of this tumor is not satisfactory. Hence, there is an urgent need to introduce innovative solutions that will prove effective even in the advanced stage of the disease. In our study, a nanosystem based on ionic silver (Ag+) bound to a carrier—Titan yellow (TY) was analyzed. The possibility of binding the thus formed TY-Ag system to Congo red (CR) and albumin (BSA) was determined. TY-Ag binding to CR provides for better nanosystem solubility and enables its targeted intracellular transport and binding to immune complexes. The binding of TY-Ag or CR-TY-Ag to albumin also protects the system against the uncontrolled release of silver ions. It will also allow the delivery of silver in a targeted manner directly to the desired site in the case of intravenous administration of such a system. In this study, the MIC (Minimum Inhibitory Concentration) and MBC (Minimum Bactericidal Concentration) values of the TY-Ag or BSA-TY-Ag systems were determined in two reference strains (Escherichia coli and Staphylococcus aureus). The paper presents nanosystems with a size of about 40–50 nm, with an intense antibacterial effect obtained at concentrations of 0.019 mM. We have also discovered that TY-Ag free or complexed with BSA (with a minimal Ag+ dose of 15–20 mM) inhibited cancer cells proliferation. TY-Ag complex diminished migration and effectively inhibited the T24 cell viability and induced apoptosis. On the basis of the obtained results, it has been shown that the presented systems may have anti-inflammatory and antitumor properties at the same time. TY-Ag or BSA-TY-Ag are new potential drugs and may become in future important therapeutic compounds in human urinary bladder carcinoma treatment and/or potent antimicrobial factors as an alternative to antibiotics.


2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Sheng Luo ◽  
Wenjin Wang ◽  
Jingfang Feng ◽  
Rui Li

Urinary bladder carcinoma refers to the commonest carcinoma with weak prognostic result for the patient as impacted by the limited treatment possibilities and challenging diagnosing process. Nevertheless, the molecular underpinning of bladder carcinoma malignant progression is still not clear. As a novel core part of pluripotency circuitry, testicular expression 10 (TEX10) plays an actively noticeable effect on reprogramming, early embryo development, and embryonic stem cell self-renewal. Nevertheless, TEX10 expressions and functions within bladder carcinoma are still not known. The present work is aimed at revealing TEX10 expression and biological function within urinary bladder carcinoma and elucidating the potential mechanisms. Results showed that TEX10 is abundant in urinary bladder carcinoma, and its protein level was related to poor disease-free survival in a positive manner. Reduced TEX10 level inhibited urinary bladder carcinoma cell proliferating process and metastasis in vitro and xenograft tumorigenicity in vivo. Notably, TEX10 might regulate carcinoma cell proliferating process and metastasis via XRCC6, thereby controlling the signaling of Wnt/β-catenin and DNA repair channel. Moreover, TEX10 gene knockout reduced the radiotherapy resistance of urinary bladder carcinoma. In brief, this work revealed that TEX10 could exert a significant carcinogenic effect on urinary bladder carcinoma tumorigenesis and radiotherapy resistance through the activation of XRCC6-related channels. Accordingly, targeting TEX10 is likely to offer a novel and feasible therapeutically related strategy for inhibiting urinary bladder carcinoma tumorigenicity.


Bioengineered ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 11376-11389
Author(s):  
Shuangquan Lin ◽  
Lei Wang ◽  
Zimin Shi ◽  
Anyi Zhu ◽  
Gan Zhang ◽  
...  

Author(s):  
Francesco Pierconti ◽  
Maurizio Martini ◽  
Tonia Cenci ◽  
Vincenzo Fiorentino ◽  
Luca Di Gianfrancesco ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document